GIM
GSK icon

Guardian Investment Management’s GSK GSK Stock Holding History

Guardian Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21,280
Closed -$1.16M – 57
2022
Q2 		$1.16M Hold
21,280
– – 1.01% 36
2022
Q1 		$1.16M Hold
21,280
– – 0.9% 41
2021
Q4 		$1.17M Buy
21,280
+400
+2% +$20.8K 0.82% 37
2021
Q3 		$997K Sell
20,880
-11,600
-36% -$583K 0.74% 38
2021
Q2 		$1.62M Buy
32,480
+160
+0.5% +$7.69K 1.11% 30
2021
Q1 		$1.44M Buy
32,320
+1,600
+5% +$72.6K 1.02% 33
2020
Q4 		$1.41M Buy
30,720
+680
+2% +$31.2K 1.07% 33
2020
Q3 		$1.41M Hold
30,040
– – 1.23% 31
2020
Q2 		$1.53M Buy
30,040
+4,080
+16% +$209K 1.39% 27
2020
Q1 		$1.23M Hold
25,960
– – 1.26% 30
2019
Q4 		$1.52M Sell
25,960
-200
-0.8% -$11.1K 1.21% 30
2019
Q3 		$1.4M Hold
26,160
– – 1.24% 32
2019
Q2 		$1.31M Sell
26,160
-1,880
-7% -$94.3K 1.14% 34
2019
Q1 		$1.47M Sell
28,040
-2,880
-9% -$144K 1.27% 32
2018
Q4 		$1.48M Sell
30,920
-1,320
-4% -$65K 1.36% 29
2018
Q3 		$1.62M Sell
32,240
-400
-1% -$20.3K 1.42% 26
2018
Q2 		$1.64M Buy
32,640
+12,240
+60% +$616K 1.57% 23
2018
Q1 		$996K Buy
20,400
+1,560
+8% +$72.7K 1.06% 33
2017
Q4 		$835K Buy
18,840
+1,680
+10% +$77.6K 0.88% 35
2017
Q3 		$871K Buy
17,160
+280
+2% +$14.2K 0.96% 35
2017
Q2 		$910K Buy
16,880
+400
+2% +$21.3K 1.01% 33
2017
Q1 		$868K Sell
16,480
-1,440
-8% -$73K 0.94% 35
2016
Q4 		$863K Buy
17,920
+240
+1% +$11.9K 1% 36
2016
Q3 		$958K Hold
17,680
– – 1.07% 35
2016
Q2 		$958K Buy
17,680
+960
+6% +$50.6K 1.07% 35
2016
Q1 		$847K Buy
+16,720
New +$833K 0.97% 39

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Guardian Investment Management's GSK Position: Q3 2022 in Review

Guardian Investment Management sold out of GSK (GSK) in Q3 2022, closing a stake of 21,280 shares — an estimated $1.16M sold.

Guardian Investment Management first reported a position in GSK in Q1 2016 and held it in 26 quarters. The position peaked at $1.64M in Q2 2018. 743 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Guardian Investment Management reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Guardian Investment Management sold 21,280 GSK shares in Q3 2022, an estimated $1.16M.
  • Guardian Investment Management first reported a position in GSK in Q1 2016 and held it in 26 quarters.
  • Guardian Investment Management's GSK position peaked at $1.64M in Q2 2018.
  • 743 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Guardian Investment Management's 13F filing for Q3 2022, filed 12 Oct 2022.